Health Condition 1: null- All Patients Recruited In Milann Fertility Centre For Art Patients In Whom 4 Germinal Vesicles Can Be Retrieved Patients Aged Between 25 And 40 Years Will Be Included
Conditions
Interventions
Intervention1: Cilostamide: Cilostamide which is the PDE3 Inhibitor to modulate nuclear-cytoplasmic synchrony in oocytes.
Its a two step invitro -media culture(control and study arm).
Invitro maturati
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: 1.All The Patients Recruited In Milann Fertility Centre For Art 2.Patients In Whom 4 Germinal Vesicles Can Be Retrieved 3.Patients Aged Between 25 And 40 Years Will Be Included 4.Patients Who Are Willing To Participate In The Research Study
Exclusion criteria
Exclusion criteria: 1.Patients Who Are Suffering From Sexually Transmitted Diseases 2.Patients Aged Above 40 Years 3.Patients Who Are Not Willing To Participate In The Study 4.Male Partner Whose Sperms Have Abnormal Morphology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maturational status of the oocytesTimepoint: 48 Hours | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the effect of Cilostamide on meiotic resumption and embryonic development of immature human oocytes.Timepoint: 5-7 day | — |
Countries
India
Contacts
Public ContactMohammed Ashraf C
NITTE University
Outcome results
None listed